2019
DOI: 10.1007/s11325-019-01794-7
|View full text |Cite
|
Sign up to set email alerts
|

Using benzodiazepines and Z-drugs for managing primary insomnia in adults in Saudi Arabia: an e-Delphi study to aid the development of clinical guidelines

Abstract: PurposeThis study aims to obtain consensus statements required for the development of clinical guidelines for the use of benzodiazepines (BZDs) and Z-drugs for the management of primary insomnia in adults in Saudi Arabia.MethodsThree rounds of the e-Delphi technique using a Bristol Online Survey (BOS) were conducted between May and August 2018. The Director of the Saudi Sleep Medicine Group helped recruit the country’s sleep medicine experts. Snowballing was used to forward invitation emails, information sheet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 20 publications
1
1
0
Order By: Relevance
“…The findings of this study indicate that patients usually receive sleep medication as a first-line treatment rather than non-pharmacological treatment. This finding is consistent with a previous study by our group indicating that patients in Saudi Arabia are not receiving CBT-I [14], even though it is recommended as initial therapy by many clinical guidelines [19][20][21] and by many experts in Saudi Arabia [22]. This might be due to Saudi physicians' lack of knowledge about non-pharmacological treatment modalities for primary insomnia or their not having the time or expertise to deliver nonpharmacological treatment to patients [15].…”
Section: Discussionsupporting
confidence: 90%
“…The findings of this study indicate that patients usually receive sleep medication as a first-line treatment rather than non-pharmacological treatment. This finding is consistent with a previous study by our group indicating that patients in Saudi Arabia are not receiving CBT-I [14], even though it is recommended as initial therapy by many clinical guidelines [19][20][21] and by many experts in Saudi Arabia [22]. This might be due to Saudi physicians' lack of knowledge about non-pharmacological treatment modalities for primary insomnia or their not having the time or expertise to deliver nonpharmacological treatment to patients [15].…”
Section: Discussionsupporting
confidence: 90%
“…Furthermore, there is no definitive number of rounds, instead, rounds usually continue until consensus on the relevant outcome/s has been reached [ 50 ], with 2–4 rounds being most common [ 52 ]. Finally, there is no defined point at which consensus is reached in a round; however, 70% agreement on items is widely accepted as having reached consensus [ 51 ].…”
Section: Methodsmentioning
confidence: 99%